Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 6
2015 10
2016 19
2017 15
2018 22
2019 14
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

81 results
Results by year
Filters applied: . Clear all
Page 1
Antibody-mediated protection against Ebola virus.
Saphire EO, Schendel SL, Gunn BM, Milligan JC, Alter G. Saphire EO, et al. Nat Immunol. 2018 Nov;19(11):1169-1178. doi: 10.1038/s41590-018-0233-9. Epub 2018 Oct 17. Nat Immunol. 2018. PMID: 30333617 Free PMC article. Review.
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection.
Saphire EO, Schendel SL, Fusco ML, Gangavarapu K, Gunn BM, Wec AZ, Halfmann PJ, Brannan JM, Herbert AS, Qiu X, Wagh K, He S, Giorgi EE, Theiler J, Pommert KBJ, Krause TB, Turner HL, Murin CD, Pallesen J, Davidson E, Ahmed R, Aman MJ, Bukreyev A, Burton DR, Crowe JE Jr, Davis CW, Georgiou G, Krammer F, Kyratsous CA, Lai JR, Nykiforuk C, Pauly MH, Rijal P, Takada A, Townsend AR, Volchkov V, Walker LM, Wang CI, Zeitlin L, Doranz BJ, Ward AB, Korber B, Kobinger GP, Andersen KG, Kawaoka Y, Alter G, Chandran K, Dye JM; Viral Hemorrhagic Fever Immunotherapeutic Consortium. Saphire EO, et al. Cell. 2018 Aug 9;174(4):938-952.e13. doi: 10.1016/j.cell.2018.07.033. Cell. 2018. PMID: 30096313 Free PMC article.
Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection.
Davis CW, Jackson KJL, McElroy AK, Halfmann P, Huang J, Chennareddy C, Piper AE, Leung Y, AlbariƱo CG, Crozier I, Ellebedy AH, Sidney J, Sette A, Yu T, Nielsen SCA, Goff AJ, Spiropoulou CF, Saphire EO, Cavet G, Kawaoka Y, Mehta AK, Glass PJ, Boyd SD, Ahmed R. Davis CW, et al. Cell. 2019 May 30;177(6):1566-1582.e17. doi: 10.1016/j.cell.2019.04.036. Epub 2019 May 16. Cell. 2019. PMID: 31104840 Free PMC article.
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus.
Gunn BM, Yu WH, Karim MM, Brannan JM, Herbert AS, Wec AZ, Halfmann PJ, Fusco ML, Schendel SL, Gangavarapu K, Krause T, Qiu X, He S, Das J, Suscovich TJ, Lai J, Chandran K, Zeitlin L, Crowe JE Jr, Lauffenburger D, Kawaoka Y, Kobinger GP, Andersen KG, Dye JM, Saphire EO, Alter G. Gunn BM, et al. Cell Host Microbe. 2018 Aug 8;24(2):221-233.e5. doi: 10.1016/j.chom.2018.07.009. Cell Host Microbe. 2018. PMID: 30092199 Free PMC article.
Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein.
Gilchuk P, Kuzmina N, Ilinykh PA, Huang K, Gunn BM, Bryan A, Davidson E, Doranz BJ, Turner HL, Fusco ML, Bramble MS, Hoff NA, Binshtein E, Kose N, Flyak AI, Flinko R, Orlandi C, Carnahan R, Parrish EH, Sevy AM, Bombardi RG, Singh PK, Mukadi P, Muyembe-Tamfum JJ, Ohi MD, Saphire EO, Lewis GK, Alter G, Ward AB, Rimoin AW, Bukreyev A, Crowe JE Jr. Gilchuk P, et al. Immunity. 2018 Aug 21;49(2):363-374.e10. doi: 10.1016/j.immuni.2018.06.018. Epub 2018 Jul 17. Immunity. 2018. PMID: 30029854 Free PMC article.
Lassa virus glycoprotein: stopping a moving target.
Hastie KM, Saphire EO. Hastie KM, et al. Curr Opin Virol. 2018 Aug;31:52-58. doi: 10.1016/j.coviro.2018.05.002. Epub 2018 May 26. Curr Opin Virol. 2018. PMID: 29843991 Free PMC article. Review.
Structural basis for antibody-mediated neutralization of Lassa virus.
Hastie KM, Zandonatti MA, Kleinfelter LM, Heinrich ML, Rowland MM, Chandran K, Branco LM, Robinson JE, Garry RF, Saphire EO. Hastie KM, et al. Science. 2017 Jun 2;356(6341):923-928. doi: 10.1126/science.aam7260. Science. 2017. PMID: 28572385 Free PMC article.
From bench to almost bedside: the long road to a licensed Ebola virus vaccine.
Wong G, Mendoza EJ, Plummer FA, Gao GF, Kobinger GP, Qiu X. Wong G, et al. Expert Opin Biol Ther. 2018 Feb;18(2):159-173. doi: 10.1080/14712598.2018.1404572. Epub 2017 Nov 17. Expert Opin Biol Ther. 2018. PMID: 29148858 Free PMC article. Review.
Achieving cross-reactivity with pan-ebolavirus antibodies.
King LB, Milligan JC, West BR, Schendel SL, Ollmann Saphire E. King LB, et al. Curr Opin Virol. 2019 Feb;34:140-148. doi: 10.1016/j.coviro.2019.01.003. Epub 2019 Mar 15. Curr Opin Virol. 2019. PMID: 30884329 Free PMC article. Review.
81 results
Jump to page
Feedback